Michael D Waller

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · The Lancet Respiratory Medicine · 2015 · 424 citations · Full text

Pharmacy, Molecular Medicine, Pharmacotherapy +17

Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia

Rebecca D’Cruz, Michael D Waller, Felicity Perrin et al. · ERJ Open Research · 2020 · 182 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +16

Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

Kevin W Southern, Carlo Castellani, Elise Lammertyn et al. · Journal of Cystic Fibrosis · 2022 · 69 citations · Full text

Medicine, Genetics, Molecular Medicine +13

Sweat Iron Loss of Male and Female Runners During Exercise

John J. LaManca, Emily M. Haymes, J. Daly et al. · International Journal of Sports Medicine · 1988 · 61 citations

Education, Physiology, Sports Medicine +15

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · Efficacy and Mechanism Evaluation · 2016 · 45 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17